chr16-24562083-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_006910.5(RBBP6):c.1211C>T(p.Ser404Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (no stars).
Frequency
Consequence
NM_006910.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
DNA sequence analysis of the RBBP6 gene demonstrated a sequence change, c.1211C>T, in exon 10 that results in an amino acid change, p.Ser404Phe. This sequence change does not appear to have been previously described in individuals with RBBP6-related disorders and has also not been described in population databases such as ExAC and gnomAD. The p.Ser404Phe change affects a highly conserved amino acid residue located in a domain of the RBBP6 protein that is not known to be functional. In-silico pathogenicity prediction tools (SIFT, PolyPhen2, Align GVGD, REVEL) provide contradictory results for the p.Ser404Phe substitution. Due to insufficient evidences and the lack of functional studies, the clinical significance of the p.Ser404Phe change remains unknown at this time. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.